Advisory Transactions

09/2018
Lifespan Biosciences, Inc.
Sale of Company to Thompson Street Capital Partners
Thompson Street Capital Partners
02/2018
Lucigen
Sale of the company to LGC Limited
LGC
07/2017
Trinean
Sale of the company to Thermo Fisher Scientific Inc.
Unchained Labs
06/2017
Trinean
Sale of the company to Unchained Labs
Unchained Labs
06/2017
LabConnect
Exclusive placement agent for LabConnect, Inc.
01/2017
Rubicon Genomics
Sale of the company to Takara Bio Inc.
Takara
11/2016
MTI-GlobalStem
Sale of the company to Thermo Fisher Scientific Inc.
Thermo Fisher Scientific
10/2016
maravai LifeSciences
Strategic acquisition of TriLink Biotechnologies
TriLink Biotechnologies
10/2016
maravai LifeSciences
Strategic acquisition of Cygnus
Cygnus Technologies
07/2016
BIOO Scientific
Sale of the company to PerkinElmer, Inc.
PerkinElmer
07/2016
Clarity Medical Systems
Clarity Medical Systems has sold its RetCam Ophthalmic
Imaging System business to Natus Medical
Natus Medical
03/2016
Pathology, Inc.
Sale of the company to Laboratory Corporation of America
LabCorp
03/2016
Maravai LifeSciences
Strategic equity investment in Vector Laboratories
Vector Laboratories, Inc.
07/2015
Sale of the company to OpGen, Inc.
09/2014
Sale of the iPS Cell Business Unit of Stemgent
to ReproCELL, Inc.
08/2014
Sale of miRInform Thyroid™ and Pancreas Test
to PDI Inc.
07/2014
Sale of company to StoneCalibre
03/2014
Equity investment and strategic collaboration with
Brooks Automation, Inc.
02/2014
Sale of in-vivo preclinical services business to
BIOQUAL, Inc.
08/2013
Sale of sequencing services business to
BioReference Laboratories, Inc.
07/2013
Sale of the Life Science business of SDIX to
OriGene Technologies, Inc.
04/2013
Sale of UVP LLC to Analytik Jena AG
12/2012
Sale of BioServices business to
Precision Bioservices
10/2012
Sale of Food Safety and GMO businesses
to Romer Labs
09/2012
Sale of preclinical in-vivo imaging business to Bruker
03/2012
Exclusive placement agent for OpGen, Inc.
12/2011
BroadOak Partners provided financial advisory
services to Quanta Biosciences
09/2011
Non-exclusive license agreement with QIAGEN
09/2011
BroadOak retained to provide ongoing financial
advisory services
09/2010
SVT gains exclusive rights in China to ENMD-2076 through
an investment in EntreMed, Inc.
07/2010
Replacement and expansion of Cayman Chemical
Company’s debt facilities
06/2010
Acquisition of Hyaluron, Inc.
04/2010
Acquisition of GlobalStem, Inc.
12/2009
Sale of in-vivo preclinical CRO services business to
Taconic Farms, Inc.
10/2009
Sale of Alpha Innotech Corp. to Cell Biosciences, Inc.
10/2009
Collaboration and license agreement with Novartis
08/2009
Sale of non-core assets to Intrexon Corporation
03/2009
Sale of Assay Designs, Inc. to Enzo Biochem, Inc.
10/2008
Sale of Semrock Inc. to IDEX Corp
04/2008
Acquisition of biodefense vaccines business from
Avecia Biologics Limited
06/2007
Sale of Fluorescent Detection Products Business
07/2006
Sale of In Vitro Technologies, Inc to Celsis International Plc
03/2006
Acquisition of sales and marketing rights to EpiPen in Canada from Allerex Laboratory
12/2005
Acquisition of Control Delivery Systems
10/2005
Sale of NovaScreen Biosciences to Caliper Life Sciences
10/2005
Merger with xtrana
07/2004
Sale of high content screening instrumentation company to BD Biosciences
07/2001
Sale of Sybron Biochemical Division to Novozymes
05/2001
Sale of publicly traded medical device company to Gyrus Group
02/2001
Sale of Munich based medical device company to ResMed
11/2000
Implementation of Shareholders Rights Plan
08/2000
Acquisition of publicly traded drug discovery tools company LJL BioSystems